These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7653402)

  • 41. Frequency of antitoxoplasma antibodies in patients with ocular pathology.
    Ally SH; Idris M
    J Ayub Med Coll Abbottabad; 2004; 16(4):75-6. PubMed ID: 15762070
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Seroprevalence and incidence of Toxoplasma gondii infection in the Legnano area of Italy.
    De Paschale M; Agrappi C; Clerici P; Mirri P; Manco MT; Cavallari S; Viganò EF
    Clin Microbiol Infect; 2008 Feb; 14(2):186-9. PubMed ID: 18034857
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Toxoplasmosis in patients with lymphoid hyperplasia of the head and neck].
    Yariktaş M; Demirci M; Döner F; Kaya S; Doğru H
    Kulak Burun Bogaz Ihtis Derg; 2004; 13(5-6):132-4. PubMed ID: 16055998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The status of infection with Toxoplasma gondii in the Swiss population: contribution of a seroepidemiologic study from the Zurich canton].
    Jacquier P; Nadal D; Zuber P; Eckert J
    Schweiz Med Wochenschr Suppl; 1995; 65():23S-28S. PubMed ID: 7716450
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of antibodies to Toxoplasma gondii in the Tel-Mond area.
    Nishri Z; Zalewski SE; Glücks L; Avni R; Lederer J; Mates A
    Isr J Med Sci; 1993 Jan; 29(1):30-2. PubMed ID: 8454443
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Anti - T. gondii antibody concentration in sera of pregnant women in the sample of Lódź population].
    Nowakowska D; Slaska M; Kostrzewska E; Wilczyński J
    Wiad Parazytol; 2001; 47 Suppl 1():83-9. PubMed ID: 16897957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Possible interactions between Toxoplasma gondii infection and the presence of non-Hodgkin's lymphoma].
    Ortiz-Muñoz AB; Cuadrado-Méndez L; Sanchis-Belenguer R
    Rev Esp Oncol; 1984; 31(2):237-45. PubMed ID: 6400214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Serological investigation on Toxoplasma gondii infection in patients with unknown central nervous system diseases].
    Li ZS; Huang YZ; Hu LY; Wang GS; Hua HY; Zhou YH
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Aug; 24(4):375, 381. PubMed ID: 23236777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Determination of antitoxoplasma IgG antibodies using the ELISA method].
    Pokorný J; Frühbauer Z; Polednáková S; Sýkora J; Zástĕra M; Fialová D
    Cesk Epidemiol Mikrobiol Imunol; 1989 Dec; 38(6):355-61. PubMed ID: 2632016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surveillance of toxoplasmosis in different groups.
    Ahmed M; Hafiz A
    J Pak Med Assoc; 1989 Jul; 39(7):183-6. PubMed ID: 2504965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of circulating antigens in immunocompromised patients during reactivation of chronic toxoplasmosis.
    Candolfi E; Derouin F; Kien T
    Eur J Clin Microbiol; 1987 Feb; 6(1):44-8. PubMed ID: 3552664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Case-control study of the presence of anti-toxoplasma antibodies in patients with hemolymphopathies and malignant neoplasms].
    Giardina MG; Amodio R; Matarazzo M; Romano F
    Nuovi Ann Ig Microbiol; 1983; 34(4):311-5. PubMed ID: 6680917
    [No Abstract]   [Full Text] [Related]  

  • 53. [Antitoxoplasma serum--derivation of the national standard (ELISA)].
    Frühbauer Z; Pokorný J; Tomásková V
    Cesk Epidemiol Mikrobiol Imunol; 1989 May; 38(3):150-4. PubMed ID: 2736632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serological survey of toxoplasmosis in the Santa Cruz region of Bolivia.
    Paradisi F; Bartoloni A; Aquilini D; Roselli M; Nunez LE; Manzone G; De Majo E; Parri F
    Trans R Soc Trop Med Hyg; 1989; 83(2):213-4. PubMed ID: 2609373
    [No Abstract]   [Full Text] [Related]  

  • 55. Prevalence of antibodies to parasitic infections in Nigerian children.
    Thomas V; Fabiyi A; Adeniyi A
    J Trop Med Hyg; 1981 Jun; 84(3):113-6. PubMed ID: 7017156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tonsilar toxoplasmosis.
    el-Fakahany AF; Abdalla KF; Younis MS; Hassan OA; el-Shantoury M
    J Egypt Soc Parasitol; 1992 Aug; 22(2):375-80. PubMed ID: 1500777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of the intrathecal synthesis of antitoxoplasma antibodies in the diagnostic assessment and in the follow-up of AIDS patients with cerebral toxoplasmosis.
    Orefice G; Carrieri PB; De Marinis T; Troisi E; Farace A; Noce S; Buscaino GA
    Acta Neurol (Napoli); 1990 Feb; 12(1):79-81. PubMed ID: 2336998
    [No Abstract]   [Full Text] [Related]  

  • 58. [Antitoxoplasma IgM studied by indirect immunofluorescence and hemagglutination: elimination of false positives and negatives by adsorption of IgG on immobilized protein A].
    Robert R; Chabasse D; Hocquet P
    Biomedicine; 1981 May; 35(2):61-5. PubMed ID: 7020782
    [No Abstract]   [Full Text] [Related]  

  • 59. The role of psychological factors in questionnaire-based studies on routes of human toxoplasmosis transmission.
    Flegr J; Hrdá S; Tachezy J
    Cent Eur J Public Health; 1998 Feb; 6(1):45-50. PubMed ID: 9524742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A report on the prevalence of toxoplasmic antibodies in Singapore.
    Singh M; Zaman V; Goh TK
    Singapore Med J; 1968 Jun; 9(2):108-10. PubMed ID: 5678587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.